In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance

References

• SainiDFazilMAliMMBabootaSAliJFormulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosisDrug Deliv201522682383624725026
   PubMed Web of Science ®Google Scholar
• WatersEAMcneelTSStevensWMFreedmanANUse of tamoxifen and raloxifene for breast cancer chemoprevention in 2010Breast Cancer Res Treat2012134287588022622807
   PubMed Web of Science ®Google Scholar
• KosakaKSakaiNEndoYImpact of intestinal glucuronidation on the pharmacokinetics of raloxifeneDrug Metab Dispos20113991495150221646435
   PubMed Web of Science ®Google Scholar
• ElsheikhMAElnaggarYSGoharEYAbdallahOYNanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisalInt J Nanomedicine201273787380222888234
   PubMed Web of Science ®Google Scholar
• Nazari-VananiRAzarpiraNHeliHKarimianKSattarahmadyNA novel self-nanoemulsifying formulation for sunitinib: Evaluation of anticancer efficacyColloids Surf B Biointerfaces2017160657228917151
   PubMed Web of Science ®Google Scholar
• QianJMengHXinLSelf-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluationColloids Surf B Biointerfaces201716010110928917148
   PubMed Web of Science ®Google Scholar
• AhmedOABadr-EldinSMTawfikMKAhmedTAEl-SayKMBadrJMDesign and optimization of self-nanoemulsifying delivery system to enhance quercetin hepatoprotective activity in paracetamol-induced hepatotoxicityJ Pharm Sci2014103260261224395640
   PubMed Web of Science ®Google Scholar
• AhmedOAAfounaMIEl-SayKMAbdel-NaimABKhedrABanjarZMOptimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride trans-dermal patchesExpert Opin Drug Deliv20141171005101324702435
   PubMed Web of Science ®Google Scholar
• AbourehabMAAhmedOABalataGFAlmalkiWHSelf-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood-brain barrierInt J Nanomedicine2018133679368729983562
   PubMed Web of Science ®Google Scholar
• DevrajRWilliamsHDWarrenDBPorterCJPoutonCWChoice of nonionic surfactant used to formulate type IIIA self-emulsifying drug delivery systems and the physicochemical properties of the drug have a pronounced influence on the degree of drug supersaturation that develops during in vitro digestionJ Pharm Sci201410341050106324470073
   PubMed Web of Science ®Google Scholar
• BasaliousEBShawkyNBadr-EldinSMSNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimizationInt J Pharm20103911–220321120214965
   PubMed Web of Science ®Google Scholar
• LeichnerCMenzelCLaffleurFBernkop-SchnürchADevelopment and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS)Int J Pharm20175301–234635328782582
   PubMedGoogle Scholar
• HekmatAAttarHSeyf KordiAAImanMJaafariMRNew oral formulation and in vitro evaluation of docetaxel-loaded nanomicellesMolecules20162191265
   PubMed Web of Science ®Google Scholar
• TripodoGChlapanidasTPerteghellaSMesenchymal stromal cells loading curcumin-INVITE-micelles: a drug delivery system for neurodegenerative diseasesColloids Surf B Biointerfaces201512530030825524221
   PubMed Web of Science ®Google Scholar
• WuJZhangHHuXReduction-sensitive mixed micelles assembled from amphiphilic prodrugs for self-codelivery of DOX and DTX with synergistic cancer therapyColloids Surf B Biointerfaces201816144945629127937
   PubMed Web of Science ®Google Scholar
• ZhangPZhangHHeWZhaoDSongALuanYDisulfide-linked amphiphilic polymer-docetaxel conjugates assembled redox-sensitive micelles for efficient antitumor drug deliveryBiomacromolecules20161751621163227018501
   PubMed Web of Science ®Google Scholar
• HuXLiuRZhangDZhangJLiZLuanYRational design of an amphiphilic chlorambucil prodrug realizing self-assembled micelles for efficient anticancer therapyACS Biomater Sci Eng201843973980
   PubMed Web of Science ®Google Scholar
• WegmannMParolaLBerteraFMNovel carvedilol paediatric nanomicelle formulation: in-vitro characterization and in-vivo evaluationJ Pharm Pharmacol201769554455327431770
   PubMed Web of Science ®Google Scholar
• WangSChenRMorottJRepkaMAWangYChenMmPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancerExpert Opin Drug Deliv201512336137325392124
   PubMed Web of Science ®Google Scholar
• SaindaneNSPagarKPVaviaPRNanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterizationAAPS PharmSciTech201314118919923255198
   PubMed Web of Science ®Google Scholar
• HosnyKMHassanAHIntranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluationInt J Pharm20144751–219119725178831
   PubMedGoogle Scholar
• PawarDJaganathanKSMucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune responseDrug Deliv201623118519424825494
   PubMed Web of Science ®Google Scholar
• SomagoniJBoakyeCHGoduguCNanomiemgel – a novel drug delivery system for topical application – in vitro and in vivo evaluationPLoS One2014912e11595225546392
   PubMed Web of Science ®Google Scholar
• GhoriMUMahdiMHSmithAMConwayBRNasal drug delivery systems: An overviewAm J Pharmacol Sci201535110119
   Google Scholar
• TronteljJVovkTBogatajMMrharAHPLC analysis of raloxifene hydrochloride and its application to drug quality control studiesPharmacol Res200552433433915979892
   PubMed Web of Science ®Google Scholar
• DateAANagarsenkerMSDesign and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetilInt J Pharm20073291–216617217010543
   PubMed Web of Science ®Google Scholar
• SayedEGHusseinAKKhaledKAAhmedOAImproved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery systemDrug Des Devel Ther2015914271435
   PubMed Web of Science ®Google Scholar
• FaridRMEtmanMANadaAHEbianAAFormulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal insertsAAPS PharmSciTech201314271271823516112
   PubMed Web of Science ®Google Scholar
• MartinacAFilipović-GrčićJVoinovichDPerissuttiBFranceschinisEDevelopment and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal deliveryInt J Pharm2005291697715707733
   PubMed Web of Science ®Google Scholar
• AhmedTAEl-SayKMAljaeidBMFahmyUAAbd-AllahFITransdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluationInt J Pharm20165001–224525426775063
   PubMed Web of Science ®Google Scholar
• EvistaScientific discussion Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000184/WC500031007.pdfAccessed May 4, 2018
   Google Scholar
• YangZYZhangZFHeXBZhaoGYZhangYQValidation of a novel HPLC method for the determination of raloxifene and its pharmacokinetics in rat plasmaChromatographia2007653–4197201
   Web of Science ®Google Scholar
• KommuruTRGurleyBKhanMAReddyIKSelf-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessmentInt J Pharm2001212223324611165081
   PubMed Web of Science ®Google Scholar
• BugginsTRDickinsonPATaylorGThe effects of pharmaceutical excipients on drug dispositionAdv Drug Deliv Rev200759151482150318198495
   PubMed Web of Science ®Google Scholar
• ChenMLLipid excipients and delivery systems for pharmaceutical development: a regulatory perspectiveAdv Drug Deliv Rev200860676877718077051
   PubMed Web of Science ®Google Scholar
• Al-MahallawiAMAbdelbaryAAAburahmaMHInvestigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicamInt J Pharm20154851–232934025796122
   PubMed Web of Science ®Google Scholar
• LiuYZhangPFengNZhangXWuSZhaoJOptimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridoninInt J Pharm20093651–213614218782611
   PubMed Web of Science ®Google Scholar
• YangCWuTQiYZhangZRecent advances in the application of Vitamin E TPGS for drug deliveryTheranostics20188246448529290821
   PubMed Web of Science ®Google Scholar
• ZhangZTanSFengSSVitamin E TPGS as a molecular biomaterial for drug deliveryBiomaterials201233194889490622498300
   PubMed Web of Science ®Google Scholar
• GuoYLuoJTanSOtienoBOZhangZThe applications of Vitamin E TPGS in drug deliveryEur J Pharm Sci201349217518623485439
   PubMed Web of Science ®Google Scholar
• HartauerKJArbuthnotGNBaertschiSWInfluence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation productPharm Dev Technol20005330331010934729
   PubMed Web of Science ®Google Scholar
• ShirkhedkarAARajputJKRajputDKSuranaSJStability-Indicating RP-TLC/densitometry determination of raloxifene hydrochloride in bulk material and in tabletsChromatography Research International20122012517
   Google Scholar
• BalasubramaniamJPanditJKIon-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochlorideDrug Deliv200310318519112944139
   PubMed Web of Science ®Google Scholar
• PaulssonMHägerströmHEdsmanKRheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditionsEur J Pharm Sci1999919910510494003
   PubMed Web of Science ®Google Scholar
• TomitaMShigaMHayashiMAwazuSHorieTIshizawaTEnhancement of colonic drug absorption by the paracellular permeation routePharm Res1988563413463244645
   PubMed Web of Science ®Google Scholar
• JainAMehraNKNaharMJainNKTopical delivery of enoxaparin using nanostructured lipid carrierJ Microencapsul201330770971523534492
   PubMed Web of Science ®Google Scholar